Translational Development Acquisition Corp. (TDAC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential
Current Price
$10.63
Price Target
—
Target Range
— — —
Analyst Rating
Buy
Forward P/E—
Trailing P/E-656.2x
Forward PEG—
Implied Growth—
Median Target—
Analyst Spread—
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
TDAC Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Translational Development Acquisition Corp. (TDAC) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $183M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, TDAC trades at a trailing P/E of -656.2x.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Financial Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+38.3%
Avg Forward P/E16.3x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NUVBNuvation Bio Inc. | $1.7B | $4.82 | $12.40 | +157.3% | Buy | — | 9 |
 HCAIHauchen AI Parking Management Technology Holding Co., Ltd. | $16M | $14.50 | — | — | — | — | — |
 GSThe Goldman Sachs Group, Inc. | $287.6B | $925.87 | $995.89 | +7.6% | Hold | 15.6x | 55 |
 MSMorgan Stanley | $302.6B | $190.18 | $205.75 | +8.2% | Buy | 16.0x | 52 |
 JPMJPMorgan Chase & Co. | $825.9B | $306.31 | $338.78 | +10.6% | Buy | 13.8x | 61 |
 EVREvercore Inc. | $13.1B | $331.04 | $382.67 | +15.6% | Buy | 17.5x | 21 |
 LAZLazard Ltd | $4.4B | $46.44 | $47.33 | +1.9% | Buy | 14.5x | 29 |
 PJTPJT Partners Inc. | $3.7B | $153.19 | $158.67 | +3.6% | Hold | 20.5x | 12 |
 RLAYRelay Therapeutics, Inc. | $2.4B | $12.51 | $21.60 | +72.7% | Buy | — | 15 |
 IMVTImmunovant, Inc. | $5.5B | $27.22 | $45.50 | +67.2% | Buy | — | 23 |
Upside Potential Comparison
NUVBRLAYIMVTEVRJPMMSGSPJTSee TDAC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TDAC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TDAC vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonTDAC — Frequently Asked Questions
Quick answers to the most common questions about buying TDAC stock.
What is the TDAC stock price target for 2026?
The consensus price target for TDAC is $N/A, close to the current price of $10.63 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
Is TDAC a buy, sell, or hold?
TDAC has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
Is TDAC stock overvalued or undervalued?
TDAC's current price is $10.63 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can TDAC stock go?
The most bullish Wall Street analyst has a price target of $N/A for TDAC, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover TDAC stock?
TDAC is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the TDAC stock forecast?
The 12-month TDAC stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
Should I buy TDAC stock?
TDAC appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do TDAC price targets vary so much?
TDAC analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.